相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Simultaneous Determination of Co-administrated Deflazacort, Aprepitant and Granisetron in Dosage Forms and Spiked Human Plasma by RP-HPLC/PAD
Mahmoud A. Tantawy et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2019)
Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin
Hideaki Yahata et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
Preparation and Pharmacokinetic Study of Aprepitant-Sulfobutyl Ether-β-Cyclodextrin Complex
Lili Ren et al.
AAPS PHARMSCITECH (2014)
Interindividual Variations in Aprepitant Plasma Pharmacokinetics in Cancer Patients Receiving Cisplatin-Based Chemotherapy for the First Time
Shinya Motohashi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2013)
Inclusion complex of aprepitant with cyclodextrin: evaluation of physico-chemical and pharmacokinetic properties
Devendra N. Ridhurkar et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2013)
Detection of aprepitant drug based on low-dimensional un-doped iron oxide nanoparticles prepared by a solution method
Mohammed M. Rahman et al.
ELECTROCHIMICA ACTA (2012)
A sensitive and rapid liquid chromatography-tandem mass spectrometry method for the quantification of the novel neurokinin-1 receptor antagonist aprepitant in rhesus macaque plasma, and cerebral spinal fluid, and human plasma with application in translational NeuroAIDs research
Di Wu et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting
Susumu Nakade et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs
SEW Huskey et al.
DRUG METABOLISM AND DISPOSITION (2004)
Simultaneous determination of Aprepitant and two metabolites in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection
CM Chavez-Eng et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2004)
Determination of a novel substance P inhibitor in human plasma by high-performance liquid chromatography with atmospheric pressure chemical ionization mass spectrometric detection using single and triple quadrupole detectors
ML Constanzer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2004)
The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human
Y Wu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant
M Bergström et al.
BIOLOGICAL PSYCHIATRY (2004)
Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets
SEW Huskey et al.
DRUG METABOLISM AND DISPOSITION (2003)
分享论文
